These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7028540)

  • 21. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Kazumi T; Hirano T; Odaka H; Ebara T; Amano N; Hozumi T; Ishida Y; Yoshino G
    Diabetes; 1996 Jun; 45(6):806-11. PubMed ID: 8635657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucocorticoid-induced hypertiglyceridemia: effects of cortisone acetate on triglyceride secretion rates and post-heparin lipolytic activity in rabbits (author's transl)].
    Mibayashi Y
    Nihon Naibunpi Gakkai Zasshi; 1978 Mar; 54(3):203-18. PubMed ID: 206474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of the mechanism of fructose-induced hypertriglyceridemia in the rat.
    Zavaroni I; Chen YD; Reaven GM
    Metabolism; 1982 Nov; 31(11):1077-83. PubMed ID: 6752639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
    Chen YD; Coulston AM; Zhou MY; Hollenbeck CB; Reaven GM
    Diabetes Care; 1995 Jan; 18(1):10-6. PubMed ID: 7698030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration.
    Vogelberg KH; Gries FA; Moschinski D
    Horm Metab Res; 1980 Dec; 12(12):688-94. PubMed ID: 7009368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.
    Johansen RF; Søndergaard E; Linnebjerg H; Garhyan P; Lam ECQ; Porksen N; Jacober SJ; Nielsen S
    Diabetes Obes Metab; 2018 Feb; 20(2):419-426. PubMed ID: 28817248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triglyceride-rich very low-density lipoproteins (VLDL) are independently associated with insulin secretion in a multiethnic cohort of adolescents.
    Tricò D; Natali A; Mari A; Ferrannini E; Santoro N; Caprio S
    Diabetes Obes Metab; 2018 Dec; 20(12):2905-2910. PubMed ID: 30003666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a new cause of defective plasma removal of very low density lipoproteins in insulin-deficient rats.
    Bar-On H; Chen YD; Reaven GM
    Diabetes; 1981 Jun; 30(6):496-9. PubMed ID: 7014312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.
    Tamasawa N; Matsui J; Murakami H; Tanabe J; Matsuki K; Ogawa Y; Ikeda Y; Takagi A; Suda T
    Diabetes Res Clin Pract; 2006 Apr; 72(1):6-11. PubMed ID: 16256241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes.
    Reaven GM; Chang H; Hoffman BB
    Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men.
    Magkos F; Patterson BW; Mohammed BS; Mittendorfer B
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1568-74. PubMed ID: 17264219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.
    Lewis GF; Uffelman KD; Szeto LW; Weller B; Steiner G
    J Clin Invest; 1995 Jan; 95(1):158-66. PubMed ID: 7814610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in lipoprotein concentrations during the development of noninsulin-dependent diabetes mellitus in obese rhesus monkeys (Macaca mulatta).
    Hannah JS; Verdery RB; Bodkin NL; Hansen BC; Le NA; Howard BV
    J Clin Endocrinol Metab; 1991 May; 72(5):1067-72. PubMed ID: 2022707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals.
    Golay A; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1081-8. PubMed ID: 3517028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why does experimental insulin deficiency lead to a decrease in removal of very low density-triglyceride from plasma?
    Verschoor L; Chen YD; Reaven GM
    Horm Metab Res; 1984 Feb; 16(2):88-91. PubMed ID: 6368352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.